Safety, Tolerability, and Pharmacokinetics of Ascending Topical Doses of TCP-25 Applied to Epidermal Suction Blister Wounds, Non-Healing Leg Ulcers and Patients With Dystrophic Epidermolysis Bullosa.

Clinical trial NCT05378997 · COMPLETED

Trial details

NCT number: NCT05378997
Sponsor: Xinnate AB
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Blister Wound of Skin Epidermolysis Bullosa Varicose Ulcer of Lower Limb

Start date: 2022-04-07
Primary completion: 2024-03-16
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.